Takahiro Sano Selected Research

Takahiro Sano Research Topics

3	Primary Myelofibrosis (Myelosclerosis) 11/2017 - 01/2017
2	Myocardial Infarction 02/2020 - 07/2011
2	Neoplasms (Cancer) 01/2018 - 06/2017
2	Fibrosis (Cirrhosis) 11/2017 - 01/2017
1	Inflammation (Inflammations) 01/2022
1	Hemorrhage 05/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2020
1	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2018
1	Proteinuria 12/2018
1	Respiratory Insufficiency (Respiratory Failure) 01/2018
1	Evans Syndrome 11/2017
1	Autoimmune Hepatitis 11/2017
1	Pancytopenia 11/2017
1	Splenomegaly 06/2017
1	Anemia 06/2017
1	Polycythemia (Erythrocytosis) 01/2017
1	Polycythemia Vera 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Immunoglobulin G4-Related Disease 08/2016
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2016
1	Lymphadenopathy 08/2016
1	Dehydration (Water Stress) 07/2014
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2002
1	Neoplasm Metastasis (Metastasis) 05/2002
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2002

2	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 05/2002
2	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 05/2002
2	Rituximab (Mabthera)FDA Link 11/2017 - 08/2016
2	Messenger RNA (mRNA)IBA 06/2017 - 07/2014
1	Phosphotransferases (Kinase)IBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 05/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2021
1	nilotinib FDA Link 02/2020
1	Lenalidomide (CC 5013)FDA Link 12/2018
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 12/2018
1	Ifosfamide FDA LinkGeneric 01/2018
1	SteroidsIBA 11/2017
1	Reticulin (Reticular Fiber)IBA 11/2017
1	ruxolitinibIBA 01/2017
1	Janus Kinase InhibitorsIBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 08/2016
1	DNA (Deoxyribonucleic Acid)IBA 08/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2016
1	Prednisolone (Predate)FDA LinkGeneric 08/2016
1	Therapeutic UsesIBA 08/2016
1	Indicators and Reagents (Reagents)IBA 07/2011
1	Topotecan (Hycamtin)FDA LinkGeneric 05/2002
1	pro-gastrin-releasing peptide (31-98)IBA 05/2002
1	Cisplatin (Platino)FDA LinkGeneric 05/2002
1	Tumor Biomarkers (Tumor Markers)IBA 05/2002
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2002
1	taxaneIBA 01/2002
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2002